Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Abivax SA (ABVX)
Abivax SA (ABVX) Notícias

ABVX

Abivax (ABVX)

Abivax SA

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ABVX

1

Data	Hora	Fonte	Título	Código	Companhia
21/02/2025	04:30	GlobeNewswire Inc.	Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025	NASDAQ:ABVX	Abivax SA
28/01/2025	04:30	GlobeNewswire Inc.	Abivax Publishes 2025 Financial Calendar	NASDAQ:ABVX	Abivax SA
23/01/2025	18:05	GlobeNewswire Inc.	Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress	NASDAQ:ABVX	Abivax SA
10/01/2025	11:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ABVX	Abivax SA
09/01/2025	13:35	GlobeNewswire Inc.	Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment	NASDAQ:ABVX	Abivax SA
23/12/2024	18:05	GlobeNewswire Inc.	Abivax Announces a Change to the Composition of its Board of Directors	NASDAQ:ABVX	Abivax SA
27/11/2024	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ABVX	Abivax SA
19/11/2024	18:30	GlobeNewswire Inc.	Abivax Establishes an At-the-Market (ATM) Program on Nasdaq	NASDAQ:ABVX	Abivax SA
19/11/2024	18:02	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:ABVX	Abivax SA
14/11/2024	18:01	GlobeNewswire Inc.	Abivax presents third quarter 2024 key financial information	NASDAQ:ABVX	Abivax SA
13/11/2024	18:01	GlobeNewswire Inc.	Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax	NASDAQ:ABVX	Abivax SA
07/10/2024	17:01	GlobeNewswire Inc.	Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation	NASDAQ:ABVX	Abivax SA
03/10/2024	17:01	GlobeNewswire Inc.	Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease	NASDAQ:ABVX	Abivax SA
03/10/2024	03:31	GlobeNewswire Inc.	Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance	NASDAQ:ABVX	Abivax SA
26/09/2024	03:30	GlobeNewswire Inc.	Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024	NASDAQ:ABVX	Abivax SA
25/09/2024	17:01	GlobeNewswire Inc.	Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model	NASDAQ:ABVX	Abivax SA
09/09/2024	17:01	GlobeNewswire Inc.	Abivax presents first-half 2024 financial results	NASDAQ:ABVX	Abivax SA
09/09/2024	07:09	IH Market News	U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns	NASDAQ:ABVX	Abivax SA
06/08/2024	03:30	GlobeNewswire Inc.	Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone	NASDAQ:ABVX	Abivax SA
15/07/2024	17:00	GlobeNewswire Inc.	Abivax Provides Operational and Key Program Update	NASDAQ:ABVX	Abivax SA
04/06/2024	17:10	GlobeNewswire Inc.	Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting	NASDAQ:ABVX	Abivax SA

Apresentando as notícias mais relevantes sobre:NASDAQ:ABVX

1

Bas Rhin department 0.04...

Voyageurs du Monde Domes...

HSBC France Domestic bon...

Financiere De L'odet

Hsbc France 2.136% may2038

Altona Rare Earths

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições